Imatinib inhibits the activity of the dysregulated PDGFRB [90], decreases enzymatic activity in DFSP cells and inhibits their ability to divide and grow [91] and induces apoptosis in tumor cells [92], which may have effects on decreasing tumor size [93]. Here, PDGFRB is linked to neoplasm.